- Title
- Combined inhibition of TGF-beta 1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to sorafenib treatment
- Creator
- Shrestha, Ritu; Prithviraj, Prashanth; Bridle, Kim; Crawford, Darrell; Jayachandran, Aparna
- Date
- 2021
- Type
- Text; Journal article
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/176898
- Identifier
- vital:15206
- Identifier
-
https://doi.org/10.3390/jcm10091889
- Identifier
- ISBN:2077-0383
- Relation
- Journal of Clinical Medicine Vol. 10, no. 9, p. 1889
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- https://creativecommons.org/licenses/by/4.0/
- Rights
- Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
- Rights
- Open Access
- Subject
- 1103 Clinical Sciences; Hepatocellular carcinoma; EMT; Immune checkpoint; Sorafenib; PD-L1
- Full Text
- Reviewed
- Funder
- The study was funded by Gallipoli Medical Research Institute and the University of Queensland.
- Hits: 1690
- Visitors: 1667
- Downloads: 92
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published version | 7 MB | Adobe Acrobat PDF | View Details Download |